Analysis identifies diverse trends in colorectal cancer screening modalities across regions, indicating significant disparities in rural and urban healthcare access.
Key Points
Colonoscopy remains the leading screening method, with an increase in utilization from 2016 to 2022 despite pandemic disruptions.
Mt-sDNA testing grew rapidly from under 1% to 17% of all screenings, while traditional methods like FOBFIT declined.
Utilization patterns revealed inequalities based on region, rurality, sex, and age, indicating varied screening uptake across demographics.
Findings underscore the need for targeted resource allocation to enhance colorectal cancer screening adherence and accessibility.